• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

EUCAST 2019 新的药敏分类定义：临床应用。

New definitions of susceptibility categories EUCAST 2019: clinic application.

机构信息

Juan M. García-Lechuz Moya, Clinical Microbiology Department. General University Hospital "Miguel Servet", Zaragoza. Spain.

出版信息

Rev Esp Quimioter. 2022 Oct;35 Suppl 3(Suppl 3):84-88. doi: 10.37201/req/s03.18.2022. Epub 2022 Oct 24.

DOI:10.37201/req/s03.18.2022
PMID:36285865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9717465/
Abstract

In January 2019, the European Committee for the Study of Antimicrobial Susceptibility (EUCAST) introduced some changes in the definitions of clinical categories for antibiotic susceptibility. The objective of these changes was to improve the credibility of category "I", optimizing and lengthening the survival and use of available antibiotics in the face of increasing antimicrobial resistance. This article aims to describe and explain these changes in the EUCAST criteria as well as make a short review about the factors on which the antibiotic susceptibility criteria depend.

摘要

2019 年 1 月，欧洲抗菌药物敏感性研究委员会（EUCAST）对抗生素药敏性临床分类定义进行了一些修改。这些变化的目的是提高类别“ I”的可信度，在面对不断增加的抗微生物药物耐药性的情况下，优化和延长现有抗生素的生存和使用。本文旨在描述和解释 EUCAST 标准中的这些变化，并简要回顾影响抗生素药敏性标准的因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81be/9717465/18500a82483e/revespquimioter-35-suppl-3-84-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81be/9717465/d165317f57e4/revespquimioter-35-suppl-3-84-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81be/9717465/18500a82483e/revespquimioter-35-suppl-3-84-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81be/9717465/d165317f57e4/revespquimioter-35-suppl-3-84-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81be/9717465/18500a82483e/revespquimioter-35-suppl-3-84-g002.jpg

相似文献

1
New definitions of susceptibility categories EUCAST 2019: clinic application.EUCAST 2019 新的药敏分类定义：临床应用。
Rev Esp Quimioter. 2022 Oct;35 Suppl 3(Suppl 3):84-88. doi: 10.37201/req/s03.18.2022. Epub 2022 Oct 24.
2
Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST).欧洲抗菌药物敏感性测试委员会（EUCAST）更新。
J Clin Microbiol. 2022 Mar 16;60(3):e0027621. doi: 10.1128/JCM.00276-21. Epub 2021 Aug 4.
3
Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study.肯尼亚内罗毕一所大学教学医院对临床实验室标准协会和欧洲抗菌药物敏感性试验委员会抗生素敏感性解读指南的比较：一项横断面研究。
Ann Clin Microbiol Antimicrob. 2016 Apr 11;15:21. doi: 10.1186/s12941-016-0135-3.
4
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing.欧洲抗菌药物敏感性试验委员会（EUCAST）抗菌药物敏感性试验技术指南
Clin Microbiol Infect. 2006 Jun;12(6):501-3. doi: 10.1111/j.1469-0691.2006.01454.x.
5
Development of a national EUCAST challenge panel for antimicrobial susceptibility testing.国家 EUCAST 药敏测试挑战板的开发。
Clin Microbiol Infect. 2016 Aug;22(8):704-10. doi: 10.1016/j.cmi.2016.05.011. Epub 2016 May 24.
6
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].[从临床和实验室标准协会（CLSI）标准转换至欧洲抗菌药物敏感性试验委员会（EUCAST）标准时尿路致病性大肠埃希菌分离株抗生素敏感性的比较]
Mikrobiyol Bul. 2015 Oct;49(4):494-501. doi: 10.5578/mb.10106.
7
From CLSI to EUCAST guidelines in the interpretation of antimicrobial susceptibility: What is the effect in our setting?从临床和实验室标准协会（CLSI）指南到欧洲抗菌药物敏感性试验委员会（EUCAST）指南对抗菌药物敏感性的解读：在我们的环境中有什么影响？
Enferm Infecc Microbiol Clin (Engl Ed). 2018 Apr;36(4):229-232. doi: 10.1016/j.eimc.2017.03.003. Epub 2017 May 4.
8
Comparison of antimicrobial susceptibility interpretation among Enterobacteriaceae using CLSI and EUCAST breakpoints.使用CLSI和EUCAST断点对肠杆菌科细菌的抗菌药物敏感性解释进行比较。
Indian J Med Microbiol. 2021 Jul;39(3):315-319. doi: 10.1016/j.ijmmb.2021.05.004. Epub 2021 May 18.
9
Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCAST.从英国抗菌化疗学会（BSAC）到欧洲抗菌药物敏感性试验委员会（EUCAST）的抗菌药物敏感性试验断点及方法
J Antimicrob Chemother. 2016 Jan;71(1):3-5. doi: 10.1093/jac/dkv287. Epub 2015 Sep 16.
10
Clinical breakpoint changes and their impact on surveillance of antimicrobial resistance in Escherichia coli causing bacteraemia.引起菌血症的大肠埃希菌的临床折点变化及其对抗菌药物耐药性监测的影响。
Clin Microbiol Infect. 2012 Nov;18(11):E466-72. doi: 10.1111/j.1469-0691.2012.03996.x. Epub 2012 Aug 27.

引用本文的文献

1
Breakpoint drift: a hidden confounder in antimicrobial resistance surveillance?断点漂移：抗菌药物耐药性监测中一个隐藏的混杂因素？
Front Microbiol. 2025 Aug 29;16:1674968. doi: 10.3389/fmicb.2025.1674968. eCollection 2025.
2
Investigating Bacterial Bloodstream Infections in Dogs and Cats: A 4-Year Surveillance in an Italian Veterinary University Hospital.犬猫细菌性血流感染的调查：意大利一家兽医大学医院的4年监测
Vet Sci. 2025 May 6;12(5):445. doi: 10.3390/vetsci12050445.
3
How AI can help us beat AMR.人工智能如何助力我们战胜抗菌药物耐药性。

本文引用的文献

1
EUCAST breakpoint categories and the revised "I": a stewardship opportunity for "I"mproving outcomes.欧洲临床微生物学和传染病学会（EUCAST）的药敏试验折点类别与修订后的“我”：改善治疗结果的管理契机
Clin Microbiol Infect. 2022 Apr;28(4):475-476. doi: 10.1016/j.cmi.2021.12.007. Epub 2021 Dec 14.
2
Impact of 2020 EUCAST criteria on meropenem prescription for the treatment of Pseudomonas aeruginosa infections: an observational study in a university hospital.2020 年 EUCAST 标准对美罗培南治疗铜绿假单胞菌感染处方的影响：一项在大学医院进行的观察性研究。
Clin Microbiol Infect. 2022 Apr;28(4):558-563. doi: 10.1016/j.cmi.2021.03.034. Epub 2021 Nov 23.
3
NPJ Antimicrob Resist. 2025 Mar 13;3(1):18. doi: 10.1038/s44259-025-00085-4.
4
Antimicrobial Resistance Patterns of Pathogens Isolated from Patients with Wound Infection at a Teaching Hospital in Vietnam.越南一家教学医院伤口感染患者分离出的病原菌的抗菌耐药模式
Infect Drug Resist. 2024 Aug 9;17:3463-3473. doi: 10.2147/IDR.S472025. eCollection 2024.
5
Current Epidemiological Status and Antibiotic Resistance Profile of ..的当前流行病学状况及抗生素耐药性概况
Antibiotics (Basel). 2024 Apr 3;13(4):323. doi: 10.3390/antibiotics13040323.
6
Gram-negative bacterial colonizations before bilateral lung transplant. The impact of 'targeted' versus 'standard' surgical prophylaxis.双肺移植前革兰氏阴性菌定植。“靶向”与“标准”手术预防策略的影响。
BMC Infect Dis. 2024 Mar 13;24(1):307. doi: 10.1186/s12879-024-09199-y.
7
Sepsis Stewardship: The Puzzle of Antibiotic Therapy in the Context of Individualization of Decision Making.脓毒症管理：个体化决策背景下抗生素治疗的难题
J Pers Med. 2024 Jan 18;14(1):106. doi: 10.3390/jpm14010106.
8
Profiling Antibiotic Susceptibility among Distinct Isolates from Dental Root Canals.分析来自牙根管的不同分离株的抗生素敏感性
Antibiotics (Basel). 2023 Dec 24;13(1):18. doi: 10.3390/antibiotics13010018.
9
Phenotypic and genomic characterization of isolates recovered from catheter-associated urinary tract infections in an Egyptian hospital.从埃及医院导管相关尿路感染中分离的 株的表型和基因组特征。
Microb Genom. 2023 Oct;9(10). doi: 10.1099/mgen.0.001125.
10
Urinary Tract Infection and Antimicrobial Resistance Patterns: 5-Year Experience in a Tertiary Pediatric Nephrology Center in the Southwestern Region of Poland.尿路感染与抗菌药物耐药模式：波兰西南部一家三级儿科肾脏病中心的5年经验
Antibiotics (Basel). 2023 Sep 19;12(9):1454. doi: 10.3390/antibiotics12091454.
Selective reporting of antibiotic susceptibility testing results: less is more.
抗生素敏感性试验结果的选择性报告：少即是多。
Clin Microbiol Infect. 2021 Apr;27(4):503-505. doi: 10.1016/j.cmi.2020.11.017. Epub 2020 Nov 27.
4
Out of Sight-Out of Mind: Impact of Cascade Reporting on Antimicrobial Usage.眼不见，心不烦：级联报告对抗菌药物使用的影响
Open Forum Infect Dis. 2020 Jan 8;7(2):ofaa002. doi: 10.1093/ofid/ofaa002. eCollection 2020 Feb.
5
Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems.西班牙药敏委员会（COESANT）关于使用自动化系统进行体外药敏研究时选择抗菌药物和浓度的推荐意见。
Enferm Infecc Microbiol Clin (Engl Ed). 2020 Apr;38(4):182-187. doi: 10.1016/j.eimc.2019.01.017. Epub 2019 Mar 14.
6
The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach.药代动力学/药效学在设定临床 MIC 折点中的作用：EUCAST 方法。
Clin Microbiol Infect. 2012 Mar;18(3):E37-45. doi: 10.1111/j.1469-0691.2011.03752.x. Epub 2012 Jan 20.